Patients with focal liver lesions of primary or secondary hepatic malignancies in whom a local ablation procedure will be carried out. C78.7 C22.0 C22.1
Conditions
Interventions
Group 1: Control group: Intravenous Analgosedation as standard procedure at the Magdeburg University Hospital.
Group 2: Test group: Different from the control group the test group additionally receive
Sponsors
Universitätsklinikum Magdeburg
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: • primary and secondary malignancies of the liver • male or female, 18+ years • Written consent to participate in all study procedures
Exclusion criteria
Exclusion criteria: Contraindications for ablative procedures: • Allergic reactions to contrast media or other substances to be injected • Poor performance status (ECOG =2) • Coagulation disorders • Bilirubin> 30 µmol / l • Symptoms of decompensated liver disease • Acute infections, local or generalized • Sepsis • Hypovolemia • Mechanical ileus • Pathologies in the region around porta hepatis
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduction of analgesic consumption (opioids, sedatives) during and after the intervention | — |
Secondary
| Measure | Time frame |
|---|---|
| Pain reduction during and after the intervention | — |
Countries
Germany
Contacts
Public ContactMarilena Georgiades
Klinik für Radiologie und Nuklearmedizin
Outcome results
None listed